Shanghai Baoji Pharmaceutical Co., Ltd. focuses on the industrialization and commercialization of recombinant protein drugs and antibody drugs. We have built a cGMP-compliant production site in Shanghai, covering an area of about 63,000 square meters. We have planned multiple production lines covering mammalian cell expression systems and Escherichia coli and yeast expression systems, as well as finished production lines for water injections, freeze-dried powder injections, and disposable pre-encapsulated formulations.
Clinical Trials
15
9 active
Approvals
1
Total approvals
Agencies
1
Regulatory bodies
Founded
2019
Active, not recruiting
7
46.7%
Completed
2
13.3%
Not yet recruiting
2
13.3%
Recruiting
4
26.7%
No news articles found
